A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia.

NCT03528681 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperkalemia

Interventions

DRUG: Sodium Zirconium Cyclosilicate 5g
DRUG: Sodium Zirconium Cyclosilicate 10g
DRUG: Placebo

Sponsor

AstraZeneca